Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry

Wacker, Julie, Humpl, Tilman, Berger, Rolf, M. F., Ivy, Dunbar, Bowers, David, Bonnet, Damien and Beghetti, Maurice (2024) Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry. Frontiers in Cardiovascular Medicine, 11. ISSN 2297-055X

[img]
Preview
Text
fcvm-11-1344014.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Aims: A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification. We aimed to analyse the applicability of an adapted clinical classification of PAH-CHD to pediatric patients using the TOPP-1 registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension) and focus on atrial septal defects (ASD) and transposition of the great arteries (TGA). Methods and results: Hemodynamic and clinical data of all patients with PAH-CHD in the TOPP cohort were reviewed. Patients were classified according to predefined ABCDE categories (A: Eisenmenger syndrome, B: left-to-right shunt, C: coincidental defects, including all ASDs, D: corrected CHD, E: TGA), or as complex CHD (group 5), by 2 independent investigators. In case of disagreement, a third reviewer could either settle a final decision, or the patient was deemed not classifiable. Survival curves were calculated for each group and compared to idiopathic PAH patients of the registry. A total of 223 out of 531 patients in the registry had PAH-CHD, and 193 were categorized to the following groups: A 39(20%), B 27(14%), C 62(32%) including 43 ASDs, D 58(30%), E 7(4%), whereas 6 patients were categorized as group 5, and 10 patients were unable to be classified. No survival difference could be demonstrated between the groups. Conclusions: This modified classification seems to be more applicable to pediatric PAH-CHD patients than the previous classification, but some patients with PAH-CHD who never had a shunt remain unclassifiable. The role of ASD in pediatric PH should be reconsidered.

Item Type: Article
Uncontrolled Keywords: pediatrics, pulmonary arterial hypertension, classification, Eisenmenger syndrome, transposition of the great arteries, pulmonary hypertension, atrial septal defect, congenital heart disease
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Health & Science > Department of Health Studies
SWORD Depositor: Pub Router
Depositing User: Pub Router
Date Deposited: 21 Feb 2024 10:08
Last Modified: 21 Feb 2024 10:08
URI: https://oars.uos.ac.uk/id/eprint/3600

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year